Aemetis reports 2023 revenue $186.7M, net loss $46.4M; India biodiesel sales up 175%

AEMETIS, INC

Q4 revenue $70.8M (up from $66.7M YoY); net loss $25.4M vs $22.4M prior year.
Full-year revenue $186.7M (down from $257M); India biodiesel segment revenue $77.2M (+175%).
Adjusted EBITDA plus IRA tax credit sales generated $32.7M positive cash flow in 2023.
Aemetis repaid $50.2M of Third Eye Capital debt; extended $108M at 8.5% interest.
Received D3 RIN approval for RNG; commissioned 36-mile biogas pipeline; increased biogas capacity 300%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AEMETIS, INC reported financial results for the fourth quarter and twelve months ended December 31, 2023.

Period: the fourth quarter and twelve months ended December 31, 2023
Result: reported results

Exact text from the filing

On March 7, 2024, Aemetis, Inc. (the “Company”) issued a press release announcing its earnings for the three and twelve months ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

AEMETIS, INC filing history →

Source: SEC EDGAR

accession 0001437749-24-006893

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.